NASDAQ:ANGO
Angiodynamics Inc.
Angiodynamics Inc.'s revenue grew 9.5% in fiscal 2026 to $320.2M while operating margin rose to −12.5%. Free cash flow was $508,000, 0.2% of revenue, and the diluted share count rose 1.6%.Summary generated from Angiodynamics Inc.'s SEC filings. Latest annual report filed Sep 29, 2026.
Key statistics
Fiscal 2026 from SEC filings. MethodologyRevenue (FY26)$320.2M
Revenue growth+9.5%
Revenue, 5-yr CAGR+1.9%
Gross margin54.6%
Operating margin−12.5%
Net margin−11.5%
ROICn/a
Return on equity−20.8%
Debt / equityn/a
Free cash flow$508,000
FCF margin0.2%
Share count change+1.6%
Financials
| Item | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 316 | 339 | 304 | 292 | 320 |
| Operating income | −28 | −51 | −192 | −40 | −40 |
| Net income | −27 | −52 | −184 | −34 | −37 |
| Free cash flow | −11 | −4 | −31 | −15 | 1 |
Recent filings
- 10-QQuarterly report for the period ended Aug 31, 2026
Oct 8, 2026 - DEF 14AProxy statement
Oct 8, 2026 - 8-KResults of operations and financial condition
Oct 8, 2026 - 8-KEntry into a material agreement
Oct 8, 2026 - 10-K/AAmended annual report for the fiscal year ended May 31, 2026
Sep 29, 2026 - 10-K/AAmended annual report for the fiscal year ended May 31, 2026
Sep 29, 2026 - 4Insider transaction report
Jul 31, 2026 - 4Insider transaction report
Jul 24, 2026